+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Kidney Disease Drug"

From
Chronic Kidney Disease Market and Forecast Analyst to 2035 - Product Thumbnail Image

Chronic Kidney Disease Market and Forecast Analyst to 2035

  • Report
  • April 2018
  • 25 Pages
  • Global
From
From
From
Polycystic Kidney Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Polycystic Kidney Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 144 Pages
  • Global
From
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2020 - Product Thumbnail Image

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 326 Pages
  • Global
From
From
From
Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2019 - Product Thumbnail Image

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 70 Pages
  • Global
From
From
From
From
Loading Indicator

The Kidney Disease Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. These drugs are used to treat a variety of conditions, including chronic kidney disease, acute kidney injury, and end-stage renal disease. They can also be used to treat other conditions such as hypertension, diabetes, and anemia. These drugs are typically prescribed by a physician and can be taken orally or intravenously. They can also be administered through dialysis or other treatments. The Kidney Disease Drug market is highly competitive, with many companies offering a variety of products. These companies include major pharmaceutical companies, as well as smaller, specialized companies. Some of the major players in the market include Pfizer, Merck, Novartis, and Sanofi. Other companies include AbbVie, AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more